Chongqing Genrix Biopharmaceutical Co., Ltd. (SHA:688443)
China · Delayed Price · Currency is CNY 25.95
-0.83 (-3.10%)
At close: Aug 21, 2026
SHA:688443 Market Cap
SHA:688443 has a market cap or net worth of 9.52 billion as of August 21, 2026. Its market cap has decreased by -22.79% in one year.
Market Cap
9.52B
Enterprise Value
8.56B
Revenue
277.82M
Ranking
n/a
PE Ratio
n/a
Stock Price
25.95
ChartMarket Cap Chart
Since June 20, 2023, SHA:688443's market cap has decreased from 12.47B to 9.52B, a decrease of -23.72%. That is a compound annual growth rate of -8.18%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 9.52B | -4.74% |
| Dec 31, 2025 | 9.99B | 8.57% |
| Dec 31, 2024 | 9.20B | -37.20% |
| Dec 29, 2023 | 14.65B | 17.43% |
| Jun 20, 2023 | 12.47B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Chengdu Olymvax Biopharmaceuticals | 11.08B |
| Staidson (Beijing) BioPharmaceuticals | 10.95B |
| Chengzhi | 10.87B |
| Pacific Shuanglin Bio-pharmacy | 10.49B |
| Beijing Hotgen Biotech | 9.78B |
| Vcanbio Cell & Gene Engineering Corp., | 9.61B |
| Jiangxi Fushine Pharmaceutical | 9.46B |
| Bio-Thera Solutions | 9.01B |